Zeroing in on an Effective Vaccine for ... - microbiology.osu.edu
microbiology.osu.edu › news › zeroing-effectiveDec 15, 2021 · While the world has spent the past two years focused on combating COVID-19, Dr. Abhay Satoskar, Ph. D., at the Ohio State University and his team of research scientists have been developing a vaccine for another devastating, but far less known disease, leishmaniasis. Satoskar, a AAAS Member, works with researchers from McGill University, the U.S. Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, Gennova Biopharmaceuticals and Nagasaki University.